Fasting serum leptin level correlateswith mid-arm fat area in peritoneal dialysis patients

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 6, 2010, Pages 583-588

  Fang, Te Chao ^a,b   Lee, Chung Jen ^c   Wang, Chih Hsien ^a,b   Liou, Hung Hsiang ^d   Hsu, Bang Gee ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

^d Hsin Jen Hospital   (Taiwan)

Author keywords

Leptin; Mid arm fat area; Peritoneal dialysis

Indexed keywords

C REACTIVE PROTEIN; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN;

ADULT; ANTHROPOMETRY; ARM CIRCUMFERENCE; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SKINFOLD THICKNESS; WAIST CIRCUMFERENCE;

ADULT; AGED; ANTHROPOMETRY; ARM; BODY FAT DISTRIBUTION; BODY WEIGHT; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMALE; HUMANS; LEPTIN; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; WAIST CIRCUMFERENCE;

EID: 78651490666     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00847.x     Document Type: Article

References (33)

1. Vázquez-Vela ME, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 2008;39:715-28.
2. Farooqi IS, O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009;89:S980-4.
3. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
4. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-70.
5. Jéquier E, Tappy L. Regulation of body weight in humans. Physiol Rev 1999;79:451-80.
6. Merabet E, Dagogo-Jack S, Coyne DW et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 1997;82:847-50.
7. Howard JK, Lord GM, Clutterbuck EJ, Ghatei MA, Pusey CD, Bloom SR. Plasma immunoreactive leptin concentration in end-stage renal disease. Clin Sci 1997;93:119-26.
8. Parry RG, Johnson DW, Carey DG et al. Serum leptin correlates with fat mass but not dietary energy intake in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1998;18: 569-75.
9. Pecoits-Filho R, Nordfors L, Heimbürger O et al. Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition. Eur J Clin Invest 2002;32:811-17.
10. Heimbürger O, Lönnqvist F, Danielsson A, Nordenström J, Stenvinkel P. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997;8:1423-30.
11. Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Ren Fail 2007;29:147-54.
12. Lee CC, Lee RP, Subeq YM, Wang CH, Fang TC, Hsu BG. Fasting serum total ghrelin level inversely correlates with metabolic syndrome in hemodialysis patients. Arch Med Res 2008;39:785-90.
13. Chowdhury SD, Ghosh T. The upper arm muscle and fat area of Santal children: an evaluation of nutritional status. Acta Paediatr 2009;98:103-6.
14. Aguilera A, Bajo MA, Rebollo F et al. Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients. Adv Perit Dial 2002;18:212-17.
15. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001;12:1046-51.
16. Wilding JP. Leptin and the control of obesity. Curr Opin Pharmacol 2001;1:656-61.
17. Tsujimoto Y, Shoji T, Tabata T et al. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1999;34:832-8.
18. Moore SE, Morgan G, Collinson AC, Swain JA, O'Connell MA, Prentice AM. Leptin, malnutrition, and immune response in rural Gambian children. Arch Dis Child 2002;87:192-7.
19. Nakatani H, Hirose H, Yamamoto Y, Saito I, Itoh H. Significance of leptin and high-molecular weight adiponectin in the general population of Japanese male adolescents. Metabolism 2008;57:157-62.
20. Chan JL, Matarese G, Shetty GK et al. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. Proc Natl Acad Sci USA 2006;103:8481-6.
21. Kalra SP. Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides 2008;29:12738.
22. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007;8:21-34.
23. Lago R, Gómez R, Lago F, Gómez-Reino J, Gualillo O. Leptin beyond body weight regulation-current concepts concerning its role in immune function and inflammation. Cell Immunol 2008;252:139-45.
24. Stenvinkel P, Lindholm B, Lönnqvist F, Katzarski K, Heimbürger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000;11:1303-9.
25. Loffreda S, Yang SQ, Lin HZ et al. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57-65.
26. Voegeling S, Fantuzzi G. Regulation of free and bound leptin and soluble leptin receptors during inflammation in mice. Cytokine 2001;14:97-103.
27. Chen K, Li F, Li J et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 2006;12:425-32.
28. Kazumi T, Kawaguchi A, Hirano T, Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high density lipoprotein-cholesterol. Metabolism 2003;52:1113-16.
29. Landt M, Parvin CA, Dagogo-Jack S, Bryant B, Coyne DW. Leptin elimination in hyperleptinaemic peritoneal dialysis patients. Nephrol Dial Transplant 1999;14:732-7.
30. Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 2001;59:1114-20.
31. Usui I, Fujisaka S, Yamazaki K et al. Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:210-14.
32. Chu CH, Lee JK, Lam HC et al. Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes. J Endocrinol Invest 2008;31: 42-7.
33. Widjaja A, Kielstein JT, Horn R, von zur Mühlen A, Kliem V, Brabant G. Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease. Nephrol Dial Transplant 2000;15:846-50.